foscarnet has been researched along with Complication, Postoperative in 27 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We describe a case of a cytomegalovirus (CMV)-seronegative kidney transplant recipient from a CMV-seropositive donor, whose course was complicated during valganciclovir prophylaxis by CMV disease, ultimately progressing to ganciclovir, foscarnet, and cidofovir resistance." | 7.85 | Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report. ( Agrawal, N; Beltran, D; Echenique, IA; Najafian, N; Ramirez-Ruiz, L, 2017) |
| "We present the case of a lung transplant recipient with disseminated crystal precipitation, and granulomatous and fibrinous inflammation after therapy with foscarnet (Foscavir; AstraZeneca, Zug, Switzerland) for recurring ganciclovir-resistant cytomegalovirus (CMV) reactivation." | 7.78 | Crystal precipitation and granulomatous inflammation in multiple organs after foscarnet therapy in a lung transplant recipient. ( Boehler, A; Gaspert, A; Schuurmans, MM; Tischler, V, 2012) |
| "Although foscarnet is a promising alternative for the treatment of cytomegalovirus (CMV) infection, its toxicity can be significant in patients with advanced age." | 7.74 | Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation. ( Hori, A; Kami, M; Kato, D; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Morinaga, S; Murashige, N; Narimatsu, H; Shibata, T; Taniguchi, S; Wake, A; Yuji, K, 2007) |
| "Cytomegalovirus (CMV) disease is a major cause of morbidity and mortality after lung transplantation despite ganciclovir prophylaxis." | 7.74 | A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome. ( Hanson, KE; Palmer, SM; Reddy, AJ; Zaas, AK, 2007) |
| "A case of acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty is reported." | 7.68 | Acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty. ( Baratz, KH; Cobo, LM; Frothingham, R; Sonkin, PL, 1992) |
| " We describe a case of a cytomegalovirus (CMV)-seronegative kidney transplant recipient from a CMV-seropositive donor, whose course was complicated during valganciclovir prophylaxis by CMV disease, ultimately progressing to ganciclovir, foscarnet, and cidofovir resistance." | 3.85 | Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report. ( Agrawal, N; Beltran, D; Echenique, IA; Najafian, N; Ramirez-Ruiz, L, 2017) |
| "We present the case of a lung transplant recipient with disseminated crystal precipitation, and granulomatous and fibrinous inflammation after therapy with foscarnet (Foscavir; AstraZeneca, Zug, Switzerland) for recurring ganciclovir-resistant cytomegalovirus (CMV) reactivation." | 3.78 | Crystal precipitation and granulomatous inflammation in multiple organs after foscarnet therapy in a lung transplant recipient. ( Boehler, A; Gaspert, A; Schuurmans, MM; Tischler, V, 2012) |
| "Although foscarnet is a promising alternative for the treatment of cytomegalovirus (CMV) infection, its toxicity can be significant in patients with advanced age." | 3.74 | Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation. ( Hori, A; Kami, M; Kato, D; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Morinaga, S; Murashige, N; Narimatsu, H; Shibata, T; Taniguchi, S; Wake, A; Yuji, K, 2007) |
| "Cytomegalovirus (CMV) disease is a major cause of morbidity and mortality after lung transplantation despite ganciclovir prophylaxis." | 3.74 | A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome. ( Hanson, KE; Palmer, SM; Reddy, AJ; Zaas, AK, 2007) |
| "A case of acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty is reported." | 3.68 | Acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty. ( Baratz, KH; Cobo, LM; Frothingham, R; Sonkin, PL, 1992) |
| "Treatment with foscarnet sodium and hypertonic saline was started with improvement of neurological condition within several days." | 1.39 | Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus-6-associated acute limbic encephalitis after unrelated bone marrow transplantation. ( Abe, D; Iseki, T; Kawaguchi, T; Kawajiri, C; Nagao, Y; Nakaseko, C; Ohwada, C; Sakai, S; Sakaida, E; Shimizu, N; Sugita, Y; Takeda, Y; Takeuchi, M; Tsukamoto, S; Yamazaki, A; Yokote, K, 2013) |
| "Treatment with foscarnet, an inhibitor of viral-DNA polymerase, in three patients with EBV-associated post-transplant lymphoproliferative disease (PTLD) after heart (n = 2) and heart/kidney transplantation (n = 1), who did not respond to, or were not eligible for reduction of immunosuppression, resulted in complete remission (48+, 27 and 15 months respectively)." | 1.31 | Identification of early antigen BZLF1/ZEBRA protein of Epstein-Barr virus can predict the effectiveness of antiviral treatment in patients with post-transplant lymphoproliferative disease. ( Anagnostopoulos, I; Hummel, MW; Jonas, S; Oertel, SH; Riess, HB, 2002) |
| "Patients with multiple myeloma and lymphoma, possibly owing to a combination of disease-related characteristics and prior immunosuppressive treatment, had high rates of CMV reactivation and may require more frequent diagnostic evaluation and prompt therapeutic intervention." | 1.31 | Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphoma. ( Bolaños-Meade, J; Buddharaju, LN; Chen, T; Cottler-Fox, M; Cross, A; Fassas, AB; Lovchik, JC; Rapoport, A; Tricot, G, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.41) | 18.7374 |
| 1990's | 6 (22.22) | 18.2507 |
| 2000's | 13 (48.15) | 29.6817 |
| 2010's | 5 (18.52) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Kuwatsuka, Y | 1 |
| Atsuta, Y | 1 |
| Hirakawa, A | 1 |
| Uchida, N | 1 |
| Inamoto, Y | 1 |
| Najima, Y | 1 |
| Ikegame, K | 1 |
| Eto, T | 1 |
| Ozawa, Y | 1 |
| Ichinohe, T | 1 |
| Inoue, M | 1 |
| Kimura, T | 1 |
| Okamoto, S | 1 |
| Miyamura, K | 1 |
| Fukuda, T | 1 |
| Bruminhent, J | 1 |
| Rotjanapan, P | 1 |
| Watcharananan, SP | 1 |
| Echenique, IA | 1 |
| Beltran, D | 1 |
| Ramirez-Ruiz, L | 1 |
| Najafian, N | 1 |
| Agrawal, N | 1 |
| Cintra-Cabrera, M | 1 |
| Suárez-Benjumea, A | 1 |
| Bernal-Blanco, G | 1 |
| González-Roncero, FM | 1 |
| Toapanta-Gaibor, NG | 1 |
| Súñer-Poblet, M | 1 |
| Pérez-Valdivia, MÁ | 1 |
| Fernández-Cuenca, F | 1 |
| Gentil-Govantes, MÁ | 1 |
| Rocha-Castilla, JL | 1 |
| Sola, E | 1 |
| Vega, E | 1 |
| Gutiérrez, C | 1 |
| López, V | 1 |
| Cabello, M | 1 |
| Burgos, D | 1 |
| González Molina, M | 1 |
| Siles, J | 1 |
| Travi, G | 1 |
| Pergam, SA | 1 |
| Xie, H | 1 |
| Boeckh, MJ | 1 |
| Tischler, V | 1 |
| Schuurmans, MM | 1 |
| Boehler, A | 1 |
| Gaspert, A | 1 |
| Kawaguchi, T | 1 |
| Takeuchi, M | 1 |
| Kawajiri, C | 1 |
| Abe, D | 1 |
| Nagao, Y | 1 |
| Yamazaki, A | 1 |
| Sugita, Y | 1 |
| Tsukamoto, S | 1 |
| Sakai, S | 1 |
| Takeda, Y | 1 |
| Ohwada, C | 1 |
| Sakaida, E | 1 |
| Shimizu, N | 1 |
| Yokote, K | 1 |
| Iseki, T | 1 |
| Nakaseko, C | 1 |
| Oertel, SH | 1 |
| Anagnostopoulos, I | 1 |
| Hummel, MW | 1 |
| Jonas, S | 1 |
| Riess, HB | 1 |
| Ronghe, MD | 1 |
| Foot, AB | 1 |
| Cornish, JM | 1 |
| Steward, CG | 1 |
| Carrington, D | 1 |
| Goulden, N | 1 |
| Marks, DI | 1 |
| Oakhill, A | 1 |
| Valdez, O | 1 |
| Gaspar, A | 1 |
| Dickson, J | 1 |
| Weigert, A | 1 |
| Machado, D | 1 |
| Halkic, N | 1 |
| Ksontini, R | 1 |
| Scholl, B | 1 |
| Blanc, C | 1 |
| Kovacsovics, T | 1 |
| Meylan, P | 1 |
| Muheim, C | 1 |
| Gillet, M | 1 |
| Mosimann, F | 1 |
| Chen, F | 1 |
| Bando, T | 1 |
| Hanaoka, N | 1 |
| Fukuse, T | 1 |
| Hasegawa, S | 1 |
| Wada, H | 1 |
| Narimatsu, H | 1 |
| Kami, M | 1 |
| Kato, D | 1 |
| Matsumura, T | 1 |
| Murashige, N | 1 |
| Kusumi, E | 1 |
| Yuji, K | 1 |
| Hori, A | 1 |
| Shibata, T | 1 |
| Masuoka, K | 1 |
| Wake, A | 1 |
| Miyakoshi, S | 1 |
| Morinaga, S | 1 |
| Taniguchi, S | 1 |
| Reddy, AJ | 1 |
| Zaas, AK | 1 |
| Hanson, KE | 1 |
| Palmer, SM | 1 |
| Le Goff, C | 1 |
| Hurault de Ligny, B | 1 |
| Freymuth, F | 2 |
| Cardineau, E | 1 |
| Lobbedez, T | 1 |
| Ryckelynck, JP | 1 |
| Petitjean, J | 1 |
| Eugene-Ruelland, G | 1 |
| Daon, F | 1 |
| Galateau, F | 1 |
| Rieux, C | 1 |
| Gautheret-Dejean, A | 1 |
| Challine-Lehmann, D | 1 |
| Kirch, C | 1 |
| Agut, H | 1 |
| Vernant, JP | 1 |
| Cole, PD | 1 |
| Stiles, J | 1 |
| Boulad, F | 1 |
| Small, TN | 1 |
| O'Reilly, RJ | 1 |
| George, D | 1 |
| Szabolcs, P | 1 |
| Kiehn, TE | 1 |
| Kernan, NA | 1 |
| Ketteler, M | 1 |
| Preuschof, L | 1 |
| Mertz, A | 1 |
| Stöffler-Meilicke, M | 1 |
| Schäfer, H | 1 |
| Distler, A | 1 |
| Offermann, G | 1 |
| Fassas, AB | 1 |
| Bolaños-Meade, J | 1 |
| Buddharaju, LN | 1 |
| Rapoport, A | 1 |
| Cottler-Fox, M | 1 |
| Chen, T | 1 |
| Lovchik, JC | 1 |
| Cross, A | 1 |
| Tricot, G | 1 |
| Crippa, F | 1 |
| Corey, L | 1 |
| Chuang, EL | 1 |
| Sale, G | 1 |
| Boeckh, M | 1 |
| Greijer, AE | 1 |
| Verschuuren, EA | 1 |
| Dekkers, CA | 1 |
| Adriaanse, HM | 1 |
| van der Bij, W | 1 |
| The, TH | 1 |
| Middeldorp, JM | 1 |
| Spratt, PM | 1 |
| Sonkin, PL | 1 |
| Baratz, KH | 1 |
| Frothingham, R | 1 |
| Cobo, LM | 1 |
| Larson, A | 1 |
| Frödin, L | 1 |
| Tufveson, G | 1 |
| Larsson, E | 1 |
| Källander, CF | 1 |
| Gronowitz, JS | 1 |
| Gluckman, E | 1 |
| Keable, H | 1 |
| Meletis, J | 1 |
| Bombail, D | 1 |
| Jolivet, I | 1 |
| Huart, JJ | 1 |
| Nebout, T | 1 |
| Cavazzana, M | 1 |
| De Castro, H | 1 |
2 reviews available for foscarnet and Complication, Postoperative
| Article | Year |
|---|---|
Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Antiviral Agents; Basiliximab; Cytomegalovirus; | 2018 |
[Cytomegalovirus infection after transplantation. Virological diagnosis, antiviral treatment].
Topics: Antibodies, Viral; Antigens, Viral; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Enzyme- | 1993 |
25 other studies available for foscarnet and Complication, Postoperative
| Article | Year |
|---|---|
Use of unapproved or off-label drugs in Japan for the treatment of graft-versus-host disease and post-transplant viral infection.
Topics: Acute Disease; Adult; Beclomethasone; Chronic Disease; Cidofovir; Cytomegalovirus Infections; Etaner | 2020 |
Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resi | 2017 |
Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report.
Topics: Aged; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Dose-Respo | 2017 |
[Disease by CMV resistant to Ganciclovir. Should plasma valganciclovir levels be monitored in high risk patients?].
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistance, Mul | 2009 |
Donor CMV serostatus not predictive of relapse in D-/R- pediatric HCT.
Topics: Acyclovir; Adolescent; Adult; Antibodies, Viral; Antigens, Viral; Antiviral Agents; Child; Child, Pr | 2009 |
Crystal precipitation and granulomatous inflammation in multiple organs after foscarnet therapy in a lung transplant recipient.
Topics: Adult; Antiviral Agents; Crystallization; Cytomegalovirus Infections; Foscarnet; Granuloma; Heart Di | 2012 |
Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus-6-associated acute limbic encephalitis after unrelated bone marrow transplantation.
Topics: Antiviral Agents; Bone Marrow Transplantation; Diagnosis, Differential; DNA, Viral; Female; Foscarne | 2013 |
Identification of early antigen BZLF1/ZEBRA protein of Epstein-Barr virus can predict the effectiveness of antiviral treatment in patients with post-transplant lymphoproliferative disease.
Topics: Adult; Antiviral Agents; DNA-Binding Proteins; Epstein-Barr Virus Infections; Foscarnet; Gene Rearra | 2002 |
The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus Infections; | 2002 |
Cytomegalovirus infection resistant to ganciclovir in a renal transplant patient.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Antiviral Agents; Cadaver; Candidiasis; Cytomegalov | 2003 |
Recurrent cytomegalovirus disease, visceral leishmaniosis, and Legionella pneumonia after liver transplantation: a case report.
Topics: Anti-Bacterial Agents; Antimony Sodium Gluconate; Antiviral Agents; Bone and Bones; Clarithromycin; | 2004 |
Early onset of ganciclovir-resistant cytomegalovirus infection in a lung-transplant recipient.
Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganc | 2005 |
Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation.
Topics: Adolescent; Adult; Aged; Antigens, Viral; Antiviral Agents; Cord Blood Stem Cell Transplantation; Cy | 2007 |
A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
Topics: Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Drug T | 2007 |
[Quantitative cytomegaloviral leukocytic antigenemia. Clinical aspects].
Topics: Antigens, Viral; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney | 1995 |
Human herpesvirus-6 meningoencephalitis in a recipient of an unrelated allogeneic bone marrow transplantation.
Topics: Acute Disease; Adult; Antiviral Agents; Bone Marrow Transplantation; Female; Foscarnet; Ganciclovir; | 1998 |
Successful treatment of human herpesvirus 6 encephalitis in a bone marrow transplant recipient.
Topics: Adolescent; Antiviral Agents; Bone Marrow Transplantation; Encephalitis, Viral; Female; Foscarnet; H | 1998 |
Fatal cytomegalovirus pneumonia after preemptive antiviral therapy in a renal transplant recipient.
Topics: Antigens, Viral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; | 2000 |
Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphoma.
Topics: Adult; Aged; Antigens, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; | 2001 |
Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
Topics: Adult; Antiviral Agents; Chronic Disease; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cyt | 2001 |
Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients.
Topics: Antigens, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA Primers; DNA Pro | 2001 |
Transplantation of the heart and lung.
Topics: Australia; Coronary Artery Disease; Costs and Cost Analysis; Cytomegalovirus Infections; Foscarnet; | 1992 |
Acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty.
Topics: Acyclovir; Administration, Oral; Animals; Drug Resistance, Microbial; Foscarnet; Humans; Keratitis, | 1992 |
Deoxythymidine kinase, a possible marker for monitoring activity of cytomegalovirus infection after renal transplantation.
Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Kidney Transplantation; Male; Middl | 1986 |
[Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Foscarnet; Gan | 1987 |